Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2009 5
2010 9
2011 11
2012 25
2013 19
2014 11
2015 20
2016 19
2017 18
2018 10
2019 9
2020 27
2021 28
2022 18
2023 23
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity.
Fu Z, Chen S, Zhu Y, Zhang D, Xie P, Jiao Q, Chi J, Xu S, Xue Y, Lu X, Song X, Cristofanilli M, Gradishar WJ, Kalinsky K, Yin Y, Zhang B, Wan Y. Fu Z, et al. Among authors: yin y. Sci Adv. 2023 Jan 6;9(1):eadd6626. doi: 10.1126/sciadv.add6626. Epub 2023 Jan 6. Sci Adv. 2023. PMID: 36608132 Free PMC article.
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial.
Xu B, Zhang Q, Zhang P, Hu X, Li W, Tong Z, Sun T, Teng Y, Wu X, Ouyang Q, Yan X, Cheng J, Liu Q, Feng J, Wang X, Yin Y, Shi Y, Pan Y, Wang Y, Xie W, Yan M, Liu Y, Yan P, Wu F, Zhu X, Zou J; DAWNA-1 Study Consortium. Xu B, et al. Among authors: yin y. Nat Med. 2021 Nov;27(11):1904-1909. doi: 10.1038/s41591-021-01562-9. Epub 2021 Nov 4. Nat Med. 2021. PMID: 34737452 Clinical Trial.
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial.
Xu B, Yan M, Ma F, Hu X, Feng J, Ouyang Q, Tong Z, Li H, Zhang Q, Sun T, Wang X, Yin Y, Cheng Y, Li W, Gu Y, Chen Q, Liu J, Cheng J, Geng C, Qin S, Wang S, Lu J, Shen K, Liu Q, Wang X, Wang H, Luo T, Yang J, Wu Y, Yu Z, Zhu X, Chen C, Zou J; PHOEBE Investigators. Xu B, et al. Among authors: yin y. Lancet Oncol. 2021 Mar;22(3):351-360. doi: 10.1016/S1470-2045(20)30702-6. Epub 2021 Feb 11. Lancet Oncol. 2021. PMID: 33581774 Clinical Trial.
Roles of tRNA-derived fragments in human cancers.
Sun C, Fu Z, Wang S, Li J, Li Y, Zhang Y, Yang F, Chu J, Wu H, Huang X, Li W, Yin Y. Sun C, et al. Among authors: yin y. Cancer Lett. 2018 Feb 1;414:16-25. doi: 10.1016/j.canlet.2017.10.031. Epub 2017 Oct 26. Cancer Lett. 2018. PMID: 29107107 Review.
Relationship between tRNA-derived fragments and human cancers.
Zeng T, Hua Y, Sun C, Zhang Y, Yang F, Yang M, Yang Y, Li J, Huang X, Wu H, Fu Z, Li W, Yin Y. Zeng T, et al. Among authors: yin y. Int J Cancer. 2020 Dec 1;147(11):3007-3018. doi: 10.1002/ijc.33107. Epub 2020 Jun 4. Int J Cancer. 2020. PMID: 32427348 Free article. Review.
The Advancing Roles of Exosomes in Breast Cancer.
Wang X, Sun C, Huang X, Li J, Fu Z, Li W, Yin Y. Wang X, et al. Among authors: yin y. Front Cell Dev Biol. 2021 Nov 1;9:731062. doi: 10.3389/fcell.2021.731062. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34790660 Free PMC article. Review.
CACA Guidelines for Holistic Integrative Management of Breast Cancer.
Wu J, Fan D, Shao Z, Xu B, Ren G, Jiang Z, Wang Y, Jin F, Zhang J, Zhang Q, Ma F, Ma J, Wang Z, Wang S, Wang X, Wang S, Wang H, Wang T, Wang X, Wang J, Wang J, Wang B, Fu L, Li H, Shi Y, Gan L, Liu Y, Liu J, Liu Z, Liu Q, Sun Q, Cheng W, Yu K, Tong Z, Wu X, Song C, Zhang J, Zhang J, Li J, Li B, Li M, Li H, Yang W, Yang H, Yang B, Bu H, Shen J, Shen Z, Chen Y, Chen C, Pang D, Fan Z, Zheng Y, Yu X, Liu G, Hu X, Ling Y, Tang J, Yin Y, Geng C, Yuan P, Gu Y, Chang C, Cao X, Sheng Y, Huang Y, Huang J, Peng W, Zeng X, Xie Y, Liao N; Committee of Breast Cancer Society, Chinese Anti-Cancer Association. Wu J, et al. Among authors: yin y. Holist Integr Oncol. 2022;1(1):7. doi: 10.1007/s44178-022-00007-8. Epub 2022 Jul 5. Holist Integr Oncol. 2022. PMID: 37520336 Free PMC article.
236 results